C

CG Oncology Inc
NASDAQ:CGON

Watchlist Manager
CG Oncology Inc
NASDAQ:CGON
Watchlist
Price: 42.45 USD 5.15% Market Closed
Market Cap: 3.4B USD

Operating Margin
CG Oncology Inc

-8 285.3%
Current
-16 410%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-8 285.3%
=
Operating Profit
-180.1m
/
Revenue
2.2m

Operating Margin Across Competitors

No Stocks Found

CG Oncology Inc
Glance View

Market Cap
3.3B USD
Industry
Biotechnology

CG Oncology Inc. is navigating the turbulent waters of biotechnology with a laser focus on the treatment of bladder cancer. Rooted deeply in the realm of oncolytic immunotherapy, the company harnesses the power of genetically modified viruses to selectively infect and destroy cancer cells. Their flagship product, CG0070, is at the heart of this endeavor, utilizing a modified adenovirus that targets tumors after traditional treatments have failed or when they present a significant clinical challenge. This targeted approach not only aims to disrupt tumor growth directly but also to stimulate a broader immune response, turning the patient's own defenses against the malignant invaders. Commercial success in this niche is predicated on the ability to navigate a highly regulated space with lengthy clinical trials and significant investment in research and development. CG Oncology makes money by progressing its therapies through these clinical development stages, eventually securing regulatory approvals. The ultimate goal is to partner with larger pharmaceutical companies or independently bring their treatments to market, capitalizing on licensing agreements, sales, and milestone payments. This reflects a strategy commonly seen in the biotech sector, where innovation and partnerships drive revenue, turning cutting-edge science into viable, life-extending products for patients and profitable ventures for investors.

CGON Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-8 285.3%
=
Operating Profit
-180.1m
/
Revenue
2.2m
What is the Operating Margin of CG Oncology Inc?

Based on CG Oncology Inc's most recent financial statements, the company has Operating Margin of -8 285.3%.

Back to Top